Skip to main content

Table 1 Demographics and clinical data at admission in the patients with HFRS of different clinical types and healthy control

From: Serum superoxide dismutase level is a potential biomarker of disease prognosis in patients with hemorrhagic fever with renal syndrome caused by the Hantaan virus

Variables

Mild (n = 64)

Moderate (n = 21)

Sever (n = 6)

Critical (n = 58)

Control (n = 30)

Age, year

42.98 ± 15.57

42.19 ± 13.75

42.83 ± 12.48

43.26 ± 18.94

42.54 ± 8.65

Gender, M/F

48/16

14/7

6/0

46/12

23/7

HFRS complication

     

 Hemorrhage, n (%)

26 (40.63)

9 (42.86)

4 (66.67)

41 (70.69)

 

 Bacterial infection

35 (54.69)

11 (52.38)

3 (50)

35 (60.34)

 

 Hepatic injury, n (%)

28 (43.75)

10 (47.62)

4 (66.67)

36 (62.07)

 

 Sepsis, n (%)

0

0

1 (16.67)

10 (17.24)

 

 MODS, n (%)

0

0

0

7 (12.07)

 

 Arrhythmia, n (%)

2 (3.13)

1 (4.76)

1 (16.67)

9 (15.52)

 

 Blood transfusion, n (%)

10 (15.63)

3 (14.28)

3 (50)

35 (60.34)

 

 CRRT, n (%)

0

0

0

31 (53.45)

 

 Hospital days

10 (3–27)

10 (5–28)

13 (5–36)

14 (5–47)

 

 Number of deaths n (%)

0

0

0

12 (20.68)

 
  1. MODS multiple organ dysfunction syndrome, CRRT continuous renal replacement therapy